Multidrug resistance and differentiation of tumor cells induced by P-glycoprotein

被引:0
|
作者
Stromskaya, TP [1 ]
Rybalkina, EY [1 ]
机构
[1] Russian Acad Med Sci, Blokhin Russian Canc Ctr, Inst Carcinogenesis, Moscow, Russia
来源
BIOLOGICHESKIE MEMBRANY | 2003年 / 20卷 / 03期
关键词
MDR1; GENE-EXPRESSION; TRANS-RETINOIC ACID; IN-VITRO; 12-O-TETRADECANOYLPHORBOL-13-ACETATE ACTIVATION; TRANSCRIPTIONAL REGULATION; MOLECULAR-MECHANISM; DRUG-RESISTANCE; LEUKEMIA-CELLS; RAS ONCOGENE; PROMOTER;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The MDR1/P-glycoprotein (Pgp) gene activation is an early event in establishment of the complex multidrug resistant (MDR) phenotype. MDR is associated with induction of the MDR gene transcription followed by translation and maturation of functional Pgp. This mechanism is up-regulated in mammalian tissues that execute of tumor cell specialized functions, implying a link between MDR and certain differentiation phenotypes. Emergence of MDR is mediated by activation of numerous signal transduction pathways including those that regulate differentiation. This review analyzed the mechanisms of coordinated regulation of differentiation during acquisition of Pgp-mediated MDR by tumor cell. We consider this problem important because conventional chemotherapeutic drugs may trigger tumor cell differentiation that, in turn, could induce the development of MDR phenotype.
引用
收藏
页码:244 / 255
页数:12
相关论文
共 50 条
  • [31] Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells
    Nanayakkara, Amila K.
    Follit, Courtney A.
    Chen, Gang
    Williams, Noelle S.
    Vogel, Pia D.
    Wise, John G.
    SCIENTIFIC REPORTS, 2018, 8
  • [32] Molecular dissection of the human multidrug resistance P-glycoprotein
    Loo, TW
    Clarke, DM
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1999, 77 (01): : 11 - 23
  • [33] P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE IN CANCER-CHEMOTHERAPY
    DEUCHARS, KL
    LING, V
    SEMINARS IN ONCOLOGY, 1989, 16 (02) : 156 - 165
  • [34] Human brain tumors: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells
    Silvia Fattori
    Francesca Becherini
    Maurizio Cianfriglia
    Giuliano Parenti
    Antonella Romanini
    Maura Castagna
    Virchows Archiv, 2007, 451 : 81 - 87
  • [35] Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
    Sikic, BI
    Fisher, GA
    Lum, BL
    Halsey, J
    BeketicOreskovic, L
    Chen, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (Suppl 1) : S13 - S19
  • [36] Multidrug resistance P-glycoprotein is not involved in cholesterol esterification
    Issandou, M
    Grand-Perret, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (02) : 369 - 377
  • [37] Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
    B. I. Sikic
    George A. Fisher
    Bert L. Lum
    Joanne Halsey
    Lidija Beketic-Oreskovic
    Gang Chen
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S13 - S19
  • [38] Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells
    Amila K. Nanayakkara
    Courtney A. Follit
    Gang Chen
    Noelle S. Williams
    Pia D. Vogel
    John G. Wise
    Scientific Reports, 8
  • [39] MULTIDRUG RESISTANCE AND P-GLYCOPROTEIN EXPRESSION IN HUMAN CANCER
    MA, DDF
    BELL, DR
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1989, 19 (06): : 736 - 743
  • [40] P-GLYCOPROTEIN IN HUMAN SARCOMA - EVIDENCE FOR MULTIDRUG RESISTANCE
    GERLACH, JH
    BELL, DR
    KARAKOUSIS, C
    SLOCUM, HK
    KARTNER, N
    RUSTUM, YM
    LING, V
    BAKER, RM
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) : 1452 - 1460